PMC:7361216 / 6042-6719 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T76","span":{"begin":54,"end":67},"obj":"Body_part"},{"id":"T77","span":{"begin":328,"end":341},"obj":"Body_part"},{"id":"T78","span":{"begin":415,"end":428},"obj":"Body_part"},{"id":"T79","span":{"begin":543,"end":546},"obj":"Body_part"},{"id":"T80","span":{"begin":630,"end":643},"obj":"Body_part"},{"id":"T81","span":{"begin":657,"end":664},"obj":"Body_part"}],"attributes":[{"id":"A76","pred":"fma_id","subj":"T76","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A77","pred":"fma_id","subj":"T77","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A78","pred":"fma_id","subj":"T78","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A79","pred":"fma_id","subj":"T79","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A80","pred":"fma_id","subj":"T80","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A81","pred":"fma_id","subj":"T81","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T13","span":{"begin":129,"end":139},"obj":"Disease"},{"id":"T14","span":{"begin":210,"end":216},"obj":"Disease"},{"id":"T15","span":{"begin":484,"end":492},"obj":"Disease"},{"id":"T16","span":{"begin":547,"end":557},"obj":"Disease"},{"id":"T17","span":{"begin":668,"end":676},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0000437"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T85","span":{"begin":72,"end":73},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T86","span":{"begin":218,"end":219},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T87","span":{"begin":345,"end":346},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T88","span":{"begin":434,"end":435},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T89","span":{"begin":579,"end":580},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T42","span":{"begin":54,"end":67},"obj":"Chemical"},{"id":"T43","span":{"begin":84,"end":91},"obj":"Chemical"},{"id":"T44","span":{"begin":328,"end":341},"obj":"Chemical"},{"id":"T45","span":{"begin":415,"end":428},"obj":"Chemical"},{"id":"T46","span":{"begin":630,"end":643},"obj":"Chemical"},{"id":"T47","span":{"begin":657,"end":664},"obj":"Chemical"}],"attributes":[{"id":"A42","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_16646"},{"id":"A43","pred":"chebi_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A44","pred":"chebi_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/CHEBI_16646"},{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_16646"},{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_16646"},{"id":"A47","pred":"chebi_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T26","span":{"begin":347,"end":354},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"},{"id":"T27","span":{"begin":392,"end":400},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T38","span":{"begin":54,"end":67},"obj":"Chemical"},{"id":"T39","span":{"begin":328,"end":341},"obj":"Chemical"},{"id":"T40","span":{"begin":415,"end":428},"obj":"Chemical"},{"id":"T41","span":{"begin":630,"end":643},"obj":"Chemical"},{"id":"T42","span":{"begin":657,"end":664},"obj":"Chemical"}],"attributes":[{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_16646"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_16646"},{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_16646"},{"id":"A41","pred":"chebi_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/CHEBI_16646"},{"id":"A42","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T18","span":{"begin":484,"end":492},"obj":"Species"},{"id":"T19","span":{"begin":668,"end":676},"obj":"Species"}],"attributes":[{"id":"A18","pred":"ncbi_taxonomy_id","subj":"T18","obj":"NCBItxid:2697049"},{"id":"A19","pred":"ncbi_taxonomy_id","subj":"T19","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T38","span":{"begin":0,"end":284},"obj":"Sentence"},{"id":"T39","span":{"begin":285,"end":462},"obj":"Sentence"},{"id":"T40","span":{"begin":463,"end":677},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"166","span":{"begin":54,"end":67},"obj":"Chemical"},{"id":"170","span":{"begin":129,"end":139},"obj":"Disease"},{"id":"171","span":{"begin":157,"end":175},"obj":"Disease"},{"id":"172","span":{"begin":198,"end":204},"obj":"Disease"},{"id":"173","span":{"begin":210,"end":216},"obj":"Disease"},{"id":"174","span":{"begin":228,"end":242},"obj":"Disease"},{"id":"167","span":{"begin":328,"end":341},"obj":"Chemical"},{"id":"168","span":{"begin":415,"end":428},"obj":"Chemical"},{"id":"175","span":{"begin":484,"end":492},"obj":"Disease"},{"id":"176","span":{"begin":543,"end":557},"obj":"Disease"},{"id":"169","span":{"begin":630,"end":643},"obj":"Chemical"},{"id":"165","span":{"begin":651,"end":656},"obj":"Gene"},{"id":"177","span":{"begin":668,"end":676},"obj":"Disease"}],"attributes":[{"id":"A175","pred":"pubann:denotes","subj":"175","obj":"MESH:C000657245"},{"id":"A177","pred":"pubann:denotes","subj":"177","obj":"MESH:C000657245"},{"id":"A166","pred":"pubann:denotes","subj":"166","obj":"MESH:D002241"},{"id":"A174","pred":"pubann:denotes","subj":"174","obj":"MESH:D001259"},{"id":"A171","pred":"pubann:denotes","subj":"171","obj":"MESH:D012678"},{"id":"A165","pred":"pubann:denotes","subj":"165","obj":"Gene:43740568"},{"id":"A172","pred":"pubann:denotes","subj":"172","obj":"MESH:D014202"},{"id":"A173","pred":"pubann:denotes","subj":"173","obj":"MESH:D001259"},{"id":"A169","pred":"pubann:denotes","subj":"169","obj":"MESH:D002241"},{"id":"A170","pred":"pubann:denotes","subj":"170","obj":"MESH:D009422"},{"id":"A176","pred":"pubann:denotes","subj":"176","obj":"MESH:D053306"},{"id":"A167","pred":"pubann:denotes","subj":"167","obj":"MESH:D002241"},{"id":"A168","pred":"pubann:denotes","subj":"168","obj":"MESH:D002241"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T69","span":{"begin":651,"end":664},"obj":"Protein"}],"attributes":[{"id":"A69","pred":"uniprot_id","subj":"T69","obj":"https://www.uniprot.org/uniprot/P31340"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T76","span":{"begin":54,"end":67},"obj":"Body_part"},{"id":"T77","span":{"begin":328,"end":341},"obj":"Body_part"},{"id":"T78","span":{"begin":415,"end":428},"obj":"Body_part"},{"id":"T79","span":{"begin":543,"end":546},"obj":"Body_part"},{"id":"T80","span":{"begin":630,"end":643},"obj":"Body_part"},{"id":"T81","span":{"begin":657,"end":664},"obj":"Body_part"}],"attributes":[{"id":"A76","pred":"fma_id","subj":"T76","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A77","pred":"fma_id","subj":"T77","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A78","pred":"fma_id","subj":"T78","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A79","pred":"fma_id","subj":"T79","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A80","pred":"fma_id","subj":"T80","obj":"http://purl.org/sig/ont/fma/fma82737"},{"id":"A81","pred":"fma_id","subj":"T81","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T16","span":{"begin":129,"end":139},"obj":"Disease"},{"id":"T17","span":{"begin":210,"end":216},"obj":"Disease"},{"id":"T18","span":{"begin":484,"end":492},"obj":"Disease"},{"id":"T19","span":{"begin":547,"end":557},"obj":"Disease"},{"id":"T20","span":{"begin":668,"end":676},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0000437"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T6","span":{"begin":129,"end":139},"obj":"Phenotype"},{"id":"T7","span":{"begin":157,"end":175},"obj":"Phenotype"},{"id":"T8","span":{"begin":177,"end":196},"obj":"Phenotype"},{"id":"T9","span":{"begin":198,"end":204},"obj":"Phenotype"},{"id":"T10","span":{"begin":210,"end":216},"obj":"Phenotype"},{"id":"T11","span":{"begin":228,"end":242},"obj":"Phenotype"},{"id":"T12","span":{"begin":253,"end":265},"obj":"Phenotype"},{"id":"T13","span":{"begin":547,"end":557},"obj":"Phenotype"}],"attributes":[{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0009830"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0001288"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0003474"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0003474"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0009830"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0001251"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0002311"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0001337"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":129,"end":139},"obj":"Phenotype"},{"id":"T7","span":{"begin":157,"end":175},"obj":"Phenotype"},{"id":"T8","span":{"begin":177,"end":196},"obj":"Phenotype"},{"id":"T9","span":{"begin":198,"end":204},"obj":"Phenotype"},{"id":"T10","span":{"begin":210,"end":216},"obj":"Phenotype"},{"id":"T11","span":{"begin":228,"end":242},"obj":"Phenotype"},{"id":"T12","span":{"begin":253,"end":265},"obj":"Phenotype"},{"id":"T13","span":{"begin":547,"end":557},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0009830"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0003474"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0001288"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0001337"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0001251"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0002311"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0003474"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0009830"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T38","span":{"begin":0,"end":284},"obj":"Sentence"},{"id":"T39","span":{"begin":285,"end":462},"obj":"Sentence"},{"id":"T40","span":{"begin":463,"end":677},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"165","span":{"begin":651,"end":656},"obj":"Gene"},{"id":"166","span":{"begin":54,"end":67},"obj":"Chemical"},{"id":"167","span":{"begin":328,"end":341},"obj":"Chemical"},{"id":"168","span":{"begin":415,"end":428},"obj":"Chemical"},{"id":"169","span":{"begin":630,"end":643},"obj":"Chemical"},{"id":"170","span":{"begin":129,"end":139},"obj":"Disease"},{"id":"171","span":{"begin":157,"end":175},"obj":"Disease"},{"id":"172","span":{"begin":198,"end":204},"obj":"Disease"},{"id":"173","span":{"begin":210,"end":216},"obj":"Disease"},{"id":"174","span":{"begin":228,"end":242},"obj":"Disease"},{"id":"175","span":{"begin":484,"end":492},"obj":"Disease"},{"id":"176","span":{"begin":543,"end":557},"obj":"Disease"},{"id":"177","span":{"begin":668,"end":676},"obj":"Disease"}],"attributes":[{"id":"A165","pred":"tao:has_database_id","subj":"165","obj":"Gene:43740568"},{"id":"A166","pred":"tao:has_database_id","subj":"166","obj":"MESH:D002241"},{"id":"A167","pred":"tao:has_database_id","subj":"167","obj":"MESH:D002241"},{"id":"A168","pred":"tao:has_database_id","subj":"168","obj":"MESH:D002241"},{"id":"A169","pred":"tao:has_database_id","subj":"169","obj":"MESH:D002241"},{"id":"A170","pred":"tao:has_database_id","subj":"170","obj":"MESH:D009422"},{"id":"A171","pred":"tao:has_database_id","subj":"171","obj":"MESH:D012678"},{"id":"A172","pred":"tao:has_database_id","subj":"172","obj":"MESH:D014202"},{"id":"A173","pred":"tao:has_database_id","subj":"173","obj":"MESH:D001259"},{"id":"A174","pred":"tao:has_database_id","subj":"174","obj":"MESH:D001259"},{"id":"A175","pred":"tao:has_database_id","subj":"175","obj":"MESH:C000657245"},{"id":"A176","pred":"tao:has_database_id","subj":"176","obj":"MESH:D053306"},{"id":"A177","pred":"tao:has_database_id","subj":"177","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Writing about these exquisite approaches to targeting carbohydrates for a potential antigen‐specific therapy for an inflammatory neuropathy characterized by sensory impairment, disturbance in gait, tremor, and ataxia (a form of incoordination following sensory loss) makes one wonder: Could such an approach, targeting critical carbohydrates in a disease, have broader applicability to other diseases where complex carbohydrates play a key pathophysiologic role? In these days of the COVID‐19 pandemic, the experiments described on monoclonal IgM neuropathy raise the issue that a similar strategy might be deployed to target the carbohydrates in the spike protein of COVID‐19."}